Search Results - "FOHLIN, Helena"

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades by TABAR, László, VITAK, Bedrich, FOHLIN, Helena, SMITH, Robert A, DUFFY, Stephen W, HSIU-HSI CHEN, Tony, MING-FANG YEN, Amy, COHEN, Anders, TOT, Tibor, YUEH-HSIA CHIU, Sherry, LI-SHENG CHEN, Sam, CHING-YUAN FANN, Jean, ROSELL, Johan

“…To estimate the long-term (29-year) effect of mammographic screening on breast cancer mortality in terms of both relative and absolute effects. This study was…”
Get full text

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up by Fohlin, Helena, Nordenskjöld, Anna, Rosell, Johan, Fernö, Mårten, Fornander, Tommy, Rydén, Lisa, Skoog, Lambert, Nordenskjöld, Bo, Stål, Olle

“…Hormone receptor positivity predicts benefit from endocrine therapy but the knowledge about the long-term survival of patients with different tumor receptor…”
Get full text

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy by Nordenskjöld, Anna, Fohlin, Helena, Rosell, Johan, Bengtsson, Nils-Olof, Fornander, Tommy, Hatschek, Thomas, Lindman, Henrik, Malmström, Per, Rydén, Lisa, Wallgren, Arne, Stål, Olle, Nordenskjöld, Bo

“…Tamoxifen is an established treatment for breast cancer, but its long-term effects on survival and on secondary cancers are not fully evaluated. We studied 30…”
Get full text

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen by Khoshnoud, Mahmoud R, Löfdahl, Britta, Fohlin, Helena, Fornander, Tommy, Stål, Olle, Skoog, Lambert, Bergh, Jonas, Nordenskjöld, Bo

“…The purpose of this study is to compare immunohistochemistry (IHC) and cytosol-based assays for determination of estrogen receptor (ER) and prediction of…”
Get full text

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer by Johansson, Henrik J, Sanchez, Betzabe C, Forshed, Jenny, Stål, Olle, Fohlin, Helena, Lewensohn, Rolf, Hall, Per, Bergh, Jonas, Lehtiö, Janne, Linderholm, Barbro K

“…Despite the success of tamoxifen since its introduction, about one-third of patients with estrogen (ER) and/or progesterone receptor (PgR) - positive breast…”
Get full text

Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer by Fohlin, Helena, Bekkhus, Tove, Sandström, Josefine, Fornander, Tommy, Nordenskjöld, Bo, Carstensen, John, Stål, Olle

“…Over the last few decades, improved and more individualized treatment has contributed to the increased survival rate of patients with breast cancer. However,…”
Get full text

Patient reported experiences of Swedish patients being investigated for cancer during the Covid-19 pandemic by Tufvesson Stiller, Helena, Schmitt-Egenolf, Marcus, Fohlin, Helena, Uppugunduri, Srinivas

“…Background Patient reported experiences in individuals being investigated for cancer have been recorded in a nationwide survey in Sweden, providing an…”
Get full text

A randomised approximation algorithm for the hitting set problem by El Ouali, Mourad, Fohlin, Helena, Srivastav, Anand

“…Let H=(V,E) be a hypergraph with vertex set V and edge set E, where n:=|V| and m:=|E|. Let l be the maximum size of an edge and Δ be the maximum vertex degree…”
Get full text

Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy by Koch, Andrea, Fohlin, Helena, Sörenson, Sverre

“…The objective of the study was to analyze if C-reactive protein (CRP) and smoking status provide prognostic information in patients with advanced non-small…”
Get more information

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy by Lagerlöf, Ingemar, Fohlin, Helena, Enblad, Gunilla, Glimelius, Bengt, Goldkuhl, Christina, Palma, Marzia, Åkesson, Lisa, Glimelius, Ingrid, Molin, Daniel

“…Balancing disease control and toxicity from chemotherapy and radiotherapy (RT) when treating early-stage classical Hodgkin lymphoma (cHL) is important…”
Get full text

Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013 by Nordenskjöld, Anna E, Fohlin, Helena, Arnesson, Lars G, Einbeigi, Zakaria, Holmberg, Erik, Albertsson, Per, Karlsson, Per

“…During the recent decades, breast cancer survival has gradually improved but there is limited knowledge on the improvement in population-based studies of…”
Get more information

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer by Nordenskjöld, Anna, Fohlin, Helena, Fornander, Tommy, Löfdahl, Britta, Skoog, Lambert, Stål, Olle

“…Purpose The independent predictive information from progesterone receptor (PgR) positivity for breast cancer treated with tamoxifen has been questioned after…”
Get full text

Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up by Chamalidou, C., Fohlin, H., Albertsson, P., Arnesson, L.-G., Einbeigi, Z., Holmberg, E., Nordenskjöld, A., Nordenskjöld, B., Karlsson, P., Linderholm, B.

“…Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare…”
Get full text

No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy by Lagerlöf, Ingemar, Holte, Harald, Glimelius, Ingrid, Björkholm, Magnus, Enblad, Gunilla, Erlanson, Martin, Fluge, Øystein, Fohlin, Helena, Fosså, Alexander, Goldkuhl, Christina, Gustavsson, Anita, Johansson, Ann‐Sofie, Linderoth, Johan, Nome, Ole, Palma, Marzia, Åkesson, Lisa, Østenstad, Bjørn, Raud, Cecilia, Glimelius, Bengt, Molin, Daniel

“…Summary When treating limited stage classical Hodgkin lymphoma (cHL), balancing treatment efficacy and toxicity is important. Toxicities after extended‐field…”
Get full text

Long-term Prognostic and Predictive Factors in Hormone Receptor Positive Breast Cancer by Fohlin, Helena

“…The breast cancer survival in Sweden is good (almost 90 % 5-year relative survival) and has increased over time. For women with hormone receptor negative…”
Get full text

An approximation algorithm for the partial vertex cover problem in hypergraphs by Ouali, Mourad El, Fohlin, Helena, Srivastav, Anand

“…Let H = ( V , E ) be a hypergraph with set of vertices V , n : = | V | and set of (hyper-)edges E , m : = | E | . Let l be the maximum size of an edge, Δ be…”
Get full text

No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study by Nordenskjöld, A.E., Fohlin, H., Albertsson, P., Arnesson, L.G., Chamalidou, C., Einbeigi, Z., Holmberg, E., Nordenskjöld, B., Karlsson, P.

“…In published radiotherapy trials, the failure rate in the control arm among patients with one to three positive nodes is high compared with that seen with…”
Get full text

RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer by Fohlin, Helena, Bekkhus, Tove, Sandström, Josefine, Fornander, Tommy, Nordenskjöld, Bo, Carstensen, John, Stål, Olle

“…The majority of breast cancer tumors are estrogen receptor-positive (ER ) and can be treated with endocrine therapy. However, certain patients may exhibit a…”
Get full text

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer by Hackshaw, Allan, Baum, Michael, Fornander, Tommy, Nordenskjold, Bo, Nicolucci, Antonio, Monson, Kathryn, Forsyth, Sharon, Reczko, Krystyna, Johansson, Ulla, Fohlin, Helena, Valentini, Miriam, Sainsbury, Richard

“…Background Systematic reviews have found that luteinizing hormone–releasing hormone (LHRH) agonists are effective in treating premenopausal women with early…”
Get full text

Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer by Fohlin, Helena, Pérez-Tenorio, Gizeh, Fornander, Tommy, Skoog, Lambert, Nordenskjöld, Bo, Carstensen, John, Stål, Olle

“…Abstract Introduction Akt is a signalling modulator for many cellular processes, including metabolism, cell proliferation, cell survival and cell growth. Three…”
Get full text